ZELGEN BIOPHARMA SAYS TO RECEIVE &100 MLN UPFRONT PAYMENT, ADDITIONAL $1.1 BLN IN MILESTONE PAYMENTS IF ABBVIE EXERCISES LICENSE OPTION

Reuters · 12/31/2025 09:30

Please log in to view news